We’re About to Cripple the Genomic Medical Era


Trumpcare needlessly cedes US leadership in data, science, and health

Over the past two years, as the Chief Data Scientist for the U.S., I’ve had the opportunity to look over the horizon and see what’s coming in advancements to medicine. First off, I couldn’t be more bullish. The costs of genetic testing continues to drop and is increasingly used to address diseases like cancer. We also now have a wide array of new sensors to understand the impact of our environments both around us (e.g., air quality) and inside us (e.g., our microbiome). These combined with with advancements of data science, machine learning, and artificial intelligence (AI) have laid the foundation to revolutionize how we treat disease.

But there’s a catch, and it’s called preexisting conditions. And bringing back preexisting conditions will derail us in three ways if the American Health Care Act (AHCA) — also known as Trumpcare, goes forward.

Read More